Literature DB >> 7363194

Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.

G J Jones, D Hewitt, G J Godin, W C Breckenridge, J Bird, M A Mishkel, G Steiner, J A Little.   

Abstract

The lipids and lipoproteins - cholesterol (C), triglyceride (TG) and high-density, low-density, very-low-density and sinking pre-beta-lipoprotein cholesterol (HDL-C, LDL-C, VLDL-C and SPB-C) - in plasma samples from 1620 fasting white adults and children from the Toronto-Hamilton area were analysed. The mean concentration of HDL-C was about 45 mg/dl in men and about 60 mg/dl in women, and the levels were constant throughout adult life in both sexes. Boys had higher mean HDL-C levels than men, but girls had lower mean HDL-C levels than women. Mean LDL-C levels, like total C levels, increased with age, from about 87 mg/dl in boys to 136 mg/dl in men, and from about 91 mg/dl in girls to 145 mg/dl in women. The mean levels of VLDL-C followed the TG patterns for age and sex, rising from about 7 mg/dl in boys to 26 mg/dl in men, and from about 11 mg/dl in girls to 19 mg/dl in women. SPB-C was detectable visually in 39% of the population and with the aid of densitometry in 54%; the levels were not related to age, sex or oral contraceptive use, and the median level was 3 mg/dl.Prevalence estimates of hyperlipoproteinemia showed that type IV was the most common, and it was found more than three times as often in men as in women. This was in part due to the customary use of plasma TG cut-off points that do not reflect the large difference in TG levels between males and females. Type IIA hyperlipoproteinemia was found in about 2% of the adults and type IIb in a further 1%. Types I, III and V were all rare. The prevalence of types II and IV hyperlipoproteinemia was four times greater in women using oral contraceptives than in nonusers in the same age range.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363194      PMCID: PMC1801586     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  33 in total

1.  The prevalence of hyperlipidemia in a natural community.

Authors:  T C Gibson; E B Whorton
Journal:  J Chronic Dis       Date:  1973-04

2.  Immunochemical quantification of human plasma Lp(a) lipoprotein.

Authors:  J J Albers; W R Hazzard
Journal:  Lipids       Date:  1974-01       Impact factor: 1.880

3.  Hyperlipoproteinemia. Prevalence in a free-living population in Albany, New York.

Authors:  D F Brown; K Daudiss
Journal:  Circulation       Date:  1973-03       Impact factor: 29.690

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.

Authors:  J Slack
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

6.  Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

Authors:  N J Stone; R I Levy; D S Fredrickson; J Verter
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

Review 7.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

8.  Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central Valley, California.

Authors:  P D Wood; M P Stern; A Silvers; G M Reaven; J von der Groeben
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

9.  Usefulness of a simple serum beta-lipoprotein assay: an epidemiological study of an active Montreal population.

Authors:  C Allard; C Goulet
Journal:  Can Med Assoc J       Date:  1967-11-25       Impact factor: 8.262

10.  Further studies on the Lp system.

Authors:  K Berg
Journal:  Vox Sang       Date:  1966 Jul-Aug       Impact factor: 2.144

View more
  9 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; D R MacLean; L Horlick; B O'Connor; A Petrasovits; J A Little
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

3.  Lipoprotein (a): genetic marker for atherosclerosis?

Authors:  W C Breckenridge
Journal:  CMAJ       Date:  1990-07-15       Impact factor: 8.262

Review 4.  Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

5.  Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey.

Authors:  Vasanth Sathiyakumar; Vincent A Pallazola; Jihwan Park; Rachit M Vakil; Peter P Toth; Mariana Lazo-Elizondo; Renato Quispe; Eliseo Guallar; Maciej Banach; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Arch Med Sci       Date:  2019-08-03       Impact factor: 3.318

6.  Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia).

Authors:  Vincent A Pallazola; Vasanth Sathiyakumar; Jihwan Park; Rachit M Vakil; Peter P Toth; Mariana Lazo-Elizondo; Emily Brown; Renato Quispe; Eliseo Guallar; Maciej Banach; Roger S Blumenthal; Steven R Jones; David Marais; Daniel Soffer; Allan D Sniderman; Seth S Martin
Journal:  Arch Med Sci       Date:  2019-08-02       Impact factor: 3.318

7.  Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education.

Authors:  P J Lupien; S Moorjani; J Rochon; G R Dagenais; L A Fleury; J Jobin; N M Robitaille
Journal:  CMAJ       Date:  1985-12-01       Impact factor: 8.262

8.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

9.  Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study.

Authors:  F Azizi; M Rahmani; A Ghanbarian; H Emami; P Salehi; P Mirmiran; N Sarbazi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.